South San Francisco, CA, United States of America

Peter A Seubert



Average Co-Inventor Count = 3.5

ph-index = 13

Forward Citations = 968(Granted Patents)


Location History:

  • San Mateo, CA (US) (1992 - 1995)
  • South San Francisco, CA (US) (1995 - 2010)
  • So. San Francisco, CA (US) (2010)

Company Filing History:


Years Active: 1992-2010

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovations of Peter A. Seubert: Pioneering Alzheimer's Diagnosis

Introduction

Peter A. Seubert is a celebrated inventor based in South San Francisco, California, with a remarkable portfolio boasting 15 patents. His groundbreaking inventions primarily focus on innovative methods for diagnosing Alzheimer's disease, contributing significantly to the medical field and the understanding of neurodegenerative disorders.

Latest Patents

Among his latest patents are advanced methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≥41) and tau. These methods involve assessing the levels of amyloid-β peptide in the cerebrospinal fluid of patients. Importantly, high levels of this peptide are generally inconsistent with a diagnosis of Alzheimer's, whereas low levels are more aligned with the disease. This patent further enhances diagnostic accuracy when combined with additional tests, leading to more reliable patient outcomes. Additionally, the patent outlines methods examining both Aβ (x-≥41) and tau levels. Specifically, low levels of Aβ and high levels of tau indicate a positive diagnosis of Alzheimer's disease, while the opposite can suggest a negative indication.

Career Highlights

Peter Seubert has made significant contributions while working with notable companies such as Athena Neurosciences, Inc. and Eli Lilly and Company. His expertise and innovative mindset have driven the development of crucial diagnostic tools that aid in the detection of Alzheimer's, improving the lives of countless individuals.

Collaborations

Throughout his career, Seubert has collaborated with other esteemed professionals, including Dale B. Schenk and Carmen Vigo-Pelfrey. These partnerships have enriched the research environment and facilitated the advancement of cutting-edge diagnostic methodologies in neurology.

Conclusion

Peter A. Seubert continues to be a pivotal figure in the realm of healthcare innovation. His dedication to enhancing the diagnosis of Alzheimer's disease through his inventive methods not only showcases his brilliance as an inventor but also his commitment to improving patient care and outcomes in neurodegenerative conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…